TL;DR
The biomarker-guided implant risk tool might represent a promising means to assess patients at high risk of developing peri-implantitis and might represent a promising means to assess patients at high risk of developing peri-implantitis.
Objectives: The long-term prognostic value of the biomarker-guided implant risk (BGIR) score was compared with two other risk models, the IDRA (implant disease risk assessment) and the PiRA (peri-implantitis risk assessment), in predicting the onset of implant diseases in patients attending a private practice and enrol...
Implant failure and peri-implantitis are associated with distinct, potentially modifiable patient- and treatment-related factors that may help identify patients and implants at increased risk of adverse outcomes.
Local factors and soft-tissue-related parameters, many modifiable during treatment planning, were associated with peri-implantitis and PISTD.
AIM To evaluate the diagnostic accuracy of host-derived and microbiological biomarkers, alone and in combination with clinical parameters, for the detection of peri-implant bone loss (BL). METHODS A university-based cohort of subjects with dental implants was examined at baseline and after a mean follow-up of 3.9 yea...
Abstract Introduction Implant-based breast reconstruction is widely performed following bilateral risk-reducing mastectomy in women at increased genetic risk of breast cancer. Although breast implants are not considered lifetime devices, there is limited evidence regarding long-term implant integrity and implant-relate...
Culture results describe viable organisms recovered from peri-implantitis cases under the study conditions and do not permit comparison with healthy implants.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
